A new, highly potent class of immunotherapeutics with unique Velcro-like binding properties can kill diverse cancer types without harming normal tissue, University of California, Irvine cancer ...
Researchers developed a 220-sample pan-cancer patient-derived organoid platform that faithfully mirrors tumors and may ...
Using an approach that includes integrating proteomics, genomics, and epigenomics data from 10 cancer types, researchers at the Baylor College of Medicine and collaborating institutions have ...
Diagnostic tools for timely, accurate and inexpensive early cancer detection that can assess risk or monitor response to treatment could help patients get the care they need faster and improve ...
Real life use of biomarkers of homologous recombination deficiency (HRD) status beyond BRCA to predict the effectiveness of PARP inhibitors in ovarian cancer patients. This is an ASCO Meeting Abstract ...
PD-L1 immunohistochemistry in gastric cancer: Comparison of combined positive score and tumor area positivity across 28-8, 22C3, and SP263 assays. Evaluation of the tumor microenvironment in African ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results